<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33919255</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>21</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Impaired 26S Proteasome Assembly Precedes Neuronal Loss in Mutant UBQLN2 Rats.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4319</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22094319</ELocationID><Abstract><AbstractText>Proteasomal dysfunction is known to be associated with amyotrophic lateral sclerosis and frontotemporal degeneration (ALS/FTD). Our previous reports have shown that a mutant form of ubiquilin-2 (UBQLN2) linked to ALS/FTD leads to neurodegeneration accompanied by accumulations of the proteasome subunit Rpt1 in transgenic rats, but the precise pathogenic mechanisms of how this mutation impairs the proteasome remains to be elucidated. Here, we reveal that this UBQLN2 mutation in rats disrupted the proteasome integrity prior to neurodegeneration, that it dissociated the 26S proteasome in vitro, and that its depletion did not affect 26S proteasome assembly. During both disease progression and in an age-dependent manner, we found that proteasome subunits were translocated to the nucleus, including both of the 20S core particles (PSMA1 and PSMB7) and the 19S regulatory particles (Rpt1 and Rpn1), suggesting that defective proteasome function may result from the proteasome-subunit mislocalization. Taken together, the present data demonstrate that impaired proteasome assembly is an early event in the pathogenesis of UBQLN2-associated neurodegeneration in mutant UBQLN2 rats.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenjuan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pathology, Anatomy &amp; Cell Biology, Thomas Jefferson University, 1020 Locust Street, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pathology, Anatomy &amp; Cell Biology, Thomas Jefferson University, 1020 Locust Street, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Limo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pathology, Anatomy &amp; Cell Biology, Thomas Jefferson University, 1020 Locust Street, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Cao</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7033-2498</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Anatomy &amp; Cell Biology, Thomas Jefferson University, 1020 Locust Street, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS095972</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS095972</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014452">Ubiquitins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000603109">Ubqln2 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="C000588630">PSMB7 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.99.-</RegistryNumber><NameOfSubstance UI="C061553">ATP dependent 26S protease</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055647" MajorTopicYN="N">Rats, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014452" MajorTopicYN="N">Ubiquitins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">FTD</Keyword><Keyword MajorTopicYN="N">UBQLN2</Keyword><Keyword MajorTopicYN="N">proteasome</Keyword><Keyword MajorTopicYN="N">protein aggregation</Keyword><Keyword MajorTopicYN="N">rat</Keyword></KeywordList><CoiStatement>The authors declare that no conflict of interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33919255</ArticleId><ArticleId IdType="pmc">PMC8122323</ArticleId><ArticleId IdType="doi">10.3390/ijms22094319</ArticleId><ArticleId IdType="pii">ijms22094319</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Deng H.X., Chen W., Hong S.T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams K.L., Warraich S.T., Yang S., Solski J.A., Fernando R., Rouleau G.A., Nicholson G.A., Blair I.P. UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis. Neurobiol. Aging. 2012;33:2527.e3&#x2013;2527.e10. doi: 10.1016/j.neurobiolaging.2012.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.05.008</ArticleId><ArticleId IdType="pubmed">22717235</ArticleId></ArticleIdList></Reference><Reference><Citation>Halloran M., Ragagnin A.M.G., Vidal M., Parakh S., Yang S., Heng B., Grima N., Shahheydari H., Soo K.Y., Blair I., et al. Amyotrophic lateral sclerosis-linked UBQLN2 mutants inhibit endoplasmic reticulum to Golgi transport, leading to Golgi fragmentation and ER stress. Cell. Mol. Life Sci. 2020;77:3859&#x2013;3873. doi: 10.1007/s00018-019-03394-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03394-w</ArticleId><ArticleId IdType="pubmed">31802140</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorrie G.H., Fecto F., Radzicki D., Weiss C., Shi Y., Dong H., Zhai H., Fu R., Liu E., Li S., et al. Dendritic spinopathy in transgenic mice expressing ALS/dementia-linked mutant UBQLN2. Proc. Natl. Acad. Sci. USA. 2014;111:14524&#x2013;14529. doi: 10.1073/pnas.1405741111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1405741111</ArticleId><ArticleId IdType="pmc">PMC4209984</ArticleId><ArticleId IdType="pubmed">25246588</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Huang B., Shi X., Gao L., Huang C. Mutant UBQLN2(P497H) in motor neurons leads to ALS-like phenotypes and defective autophagy in rats. Acta Neuropathol. Commun. 2018;6:122. doi: 10.1186/s40478-018-0627-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0627-9</ArticleId><ArticleId IdType="pmc">PMC6225656</ArticleId><ArticleId IdType="pubmed">30409191</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Liu M., Huang C., Liu X., Huang B., Li N., Zhou H., Xia X.G. Pathogenic UBQLN2 gains toxic properties to induce neuron death. Acta Neuropathol. 2015;129:417&#x2013;428. doi: 10.1007/s00401-014-1367-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1367-y</ArticleId><ArticleId IdType="pmc">PMC4777328</ArticleId><ArticleId IdType="pubmed">25388785</ArticleId></ArticleIdList></Reference><Reference><Citation>Le N.T., Chang L., Kovlyagina I., Georgiou P., Safren N., Braunstein K.E., Kvarta M.D., Van Dyke A.M., LeGates T.A., Philips T., et al. Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations. Proc. Natl. Acad. Sci. USA. 2016;113:E7580&#x2013;E7589. doi: 10.1073/pnas.1608432113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1608432113</ArticleId><ArticleId IdType="pmc">PMC5127348</ArticleId><ArticleId IdType="pubmed">27834214</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey L.M., Sandoval-Pistorius S.S., Moore S.J., Gerson J.E., Komlo R., Fischer S., Negron-Rios K.Y., Crowley E.V., Padron F., Patel R., et al. Modeling UBQLN2-mediated neurodegenerative disease in mice: Shared and divergent properties of wild type and mutant UBQLN2 in phase separation, subcellular localization, altered proteostasis pathways, and selective cytotoxicity. Neurobiol. Dis. 2020;143:105016. doi: 10.1016/j.nbd.2020.105016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105016</ArticleId><ArticleId IdType="pmc">PMC7504910</ArticleId><ArticleId IdType="pubmed">32653673</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L., Tu H., Shi S.T., Lee K.J., Asanaka M., Hwang S.B., Lai M.M. Interaction with a ubiquitin-like protein enhances the ubiquitination and degradation of hepatitis C virus RNA-dependent RNA polymerase. J. Virol. 2003;77:4149&#x2013;4159. doi: 10.1128/JVI.77.7.4149-4159.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.7.4149-4159.2003</ArticleId><ArticleId IdType="pmc">PMC150629</ArticleId><ArticleId IdType="pubmed">12634373</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R., Bett J.S., Keuss M.J., Solovyova A., McWilliams T.G., Johnson C., Sahu I., Varghese J., Wood N., Wightman M., et al. UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. Cell. 2016;166:935&#x2013;949. doi: 10.1016/j.cell.2016.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.07.001</ArticleId><ArticleId IdType="pmc">PMC5003816</ArticleId><ArticleId IdType="pubmed">27477512</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothenberg C., Srinivasan D., Mah L., Kaushik S., Peterhoff C.M., Ugolino J., Fang S., Cuervo A.M., Nixon R.A., Monteiro M.J. Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. Hum. Mol. Genet. 2010;19:3219&#x2013;3232. doi: 10.1093/hmg/ddq231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq231</ArticleId><ArticleId IdType="pmc">PMC2908472</ArticleId><ArticleId IdType="pubmed">20529957</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Mikhailov A., Kallo-Hosein H., Hara K., Yonezawa K., Avruch J. Characterization of ubiquilin 1, an mTOR-interacting protein. Biochim. Biophys. Acta BBA Mol. Cell Res. 2002;1542:41&#x2013;56. doi: 10.1016/S0167-4889(01)00164-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-4889(01)00164-1</ArticleId><ArticleId IdType="pubmed">11853878</ArticleId></ArticleIdList></Reference><Reference><Citation>Synofzik M., Maetzler W., Grehl T., Prudlo J., Vom Hagen J.M., Haack T., Rebassoo P., Munz M., Schols L., Biskup S. Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype. Neurobiol. Aging. 2012;33:2949.e13&#x2013;2949.e17. doi: 10.1016/j.neurobiolaging.2012.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.07.002</ArticleId><ArticleId IdType="pubmed">22892309</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#x2019;Diaye E.N., Kajihara K.K., Hsieh I., Morisaki H., Debnath J., Brown E.J. PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation. EMBO Rep. 2009;10:173&#x2013;179. doi: 10.1038/embor.2008.238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/embor.2008.238</ArticleId><ArticleId IdType="pmc">PMC2637314</ArticleId><ArticleId IdType="pubmed">19148225</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaka M., Ito D., Suzuki N. Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2. Biochem. Biophys. Res. Commun. 2016;472:324&#x2013;331. doi: 10.1016/j.bbrc.2016.02.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.02.107</ArticleId><ArticleId IdType="pubmed">26944018</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L., Monteiro M.J. Defective Proteasome Delivery of Polyubiquitinated Proteins by Ubiquilin-2 Proteins Containing ALS Mutations. PLoS ONE. 2015;10:e0130162. doi: 10.1371/journal.pone.0130162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0130162</ArticleId><ArticleId IdType="pmc">PMC4468220</ArticleId><ArticleId IdType="pubmed">26075709</ArticleId></ArticleIdList></Reference><Reference><Citation>He C., Klionsky D.J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 2009;43:67&#x2013;93. doi: 10.1146/annurev-genet-102808-114910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genet-102808-114910</ArticleId><ArticleId IdType="pmc">PMC2831538</ArticleId><ArticleId IdType="pubmed">19653858</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S., Li X., Kim H.M., Singh C.R., Tian G., Hoyt M.A., Lovell S., Battaile K.P., Zolkiewski M., Coffino P., et al. Reconfiguration of the proteasome during chaperone-mediated assembly. Nature. 2013;497:512&#x2013;516. doi: 10.1038/nature12123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12123</ArticleId><ArticleId IdType="pmc">PMC3687086</ArticleId><ArticleId IdType="pubmed">23644457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kish-Trier E., Hill C.P. Structural biology of the proteasome. Annu. Rev. Biophys. 2013;42:29&#x2013;49. doi: 10.1146/annurev-biophys-083012-130417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biophys-083012-130417</ArticleId><ArticleId IdType="pmc">PMC4878838</ArticleId><ArticleId IdType="pubmed">23414347</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeki Y., Tanaka K. Assembly and function of the proteasome. Methods. Mol. Biol. 2012;832:315&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pubmed">22350895</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleijnen M.F., Shih A.H., Zhou P., Kumar S., Soccio R.E., Kedersha N.L., Gill G., Howley P.M. The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. Mol. Cell. 2000;6:409&#x2013;419. doi: 10.1016/S1097-2765(00)00040-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(00)00040-X</ArticleId><ArticleId IdType="pubmed">10983987</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud L., Picher-Martel V., Codron P., Julien J.P. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. Acta. Neuropathol. Commun. 2019;7:103. doi: 10.1186/s40478-019-0758-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0758-7</ArticleId><ArticleId IdType="pmc">PMC6889556</ArticleId><ArticleId IdType="pubmed">31319884</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters K.J., Kleijnen M.F., Goh A.M., Wagner G., Howley P.M. Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a. Biochemistry. 2002;41:1767&#x2013;1777. doi: 10.1021/bi011892y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi011892y</ArticleId><ArticleId IdType="pubmed">11827521</ArticleId></ArticleIdList></Reference><Reference><Citation>Itakura E., Zavodszky E., Shao S., Wohlever M.L., Keenan R.J., Hegde R.S. Ubiquilins Chaperone and Triage Mitochondrial Membrane Proteins for Degradation. Mol. Cell. 2016;63:21&#x2013;33. doi: 10.1016/j.molcel.2016.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.05.020</ArticleId><ArticleId IdType="pmc">PMC4942676</ArticleId><ArticleId IdType="pubmed">27345149</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedford L., Hay D., Devoy A., Paine S., Powe D.G., Seth R., Gray T., Topham I., Fone K., Rezvani N., et al. Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies. J. Neurosci. 2008;28:8189&#x2013;8198. doi: 10.1523/JNEUROSCI.2218-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2218-08.2008</ArticleId><ArticleId IdType="pmc">PMC6670564</ArticleId><ArticleId IdType="pubmed">18701681</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang B., Wu Q., Zhou H., Huang C., Xia X.G. Increased Ubqln2 expression causes neuron death in transgenic rats. J. Neurochem. 2016;139:285&#x2013;293. doi: 10.1111/jnc.13748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13748</ArticleId><ArticleId IdType="pmc">PMC5117623</ArticleId><ArticleId IdType="pubmed">27456931</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J.J., Cai A., Greenslade J.E., Higgins N.R., Fan C., Le N.T.T., Tatman M., Whiteley A.M., Prado M.A., Dieriks B.V., et al. ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function. Proc. Natl. Acad. Sci. USA. 2020;117:15230&#x2013;15241. doi: 10.1073/pnas.1917371117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1917371117</ArticleId><ArticleId IdType="pmc">PMC7334651</ArticleId><ArticleId IdType="pubmed">32513711</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceballos-Diaz C., Rosario A.M., Park H.J., Chakrabarty P., Sacino A., Cruz P.E., Siemienski Z., Lara N., Moran C., Ravelo N., et al. Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice. Mol. Neurodegener. 2015;10:25. doi: 10.1186/s13024-015-0026-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-015-0026-7</ArticleId><ArticleId IdType="pmc">PMC4495639</ArticleId><ArticleId IdType="pubmed">26152284</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey L.M., Safren N., Pithadia A.S., Gerson J.E., Dulchavsky M., Fischer S., Patel R., Lantis G., Ashraf N., Kim J.H., et al. Mutant UBQLN2 promotes toxicity by modulating intrinsic self-assembly. Proc. Natl. Acad. Sci. USA. 2018;115:E10495&#x2013;E10504. doi: 10.1073/pnas.1810522115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1810522115</ArticleId><ArticleId IdType="pmc">PMC6217421</ArticleId><ArticleId IdType="pubmed">30333186</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao H.M., Hong J.S. Why neurodegenerative diseases are progressive: Uncontrolled inflammation drives disease progression. Trends Immunol. 2008;29:357&#x2013;365. doi: 10.1016/j.it.2008.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2008.05.002</ArticleId><ArticleId IdType="pmc">PMC4794280</ArticleId><ArticleId IdType="pubmed">18599350</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Zhang W., Huang B., Chen X., Huang C. UBQLN2 Promotes the Production of Type I Interferon via the TBK1-IRF3 Pathway. Cells. 2020;9:1205. doi: 10.3390/cells9051205.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9051205</ArticleId><ArticleId IdType="pmc">PMC7290724</ArticleId><ArticleId IdType="pubmed">32413959</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Tong J., Bi F., Zhou H., Xia X.G. Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats. J. Clin. Investig. 2012;122:107&#x2013;118. doi: 10.1172/JCI59130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI59130</ArticleId><ArticleId IdType="pmc">PMC3248298</ArticleId><ArticleId IdType="pubmed">22156203</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>